Volume 19, Issue 1 (4-2009)                   JHNM 2009, 19(1): 1-7 | Back to browse issues page

XML Print


1- , maryam_ e mousavi@ yahoo.com
Abstract:   (4791 Views)

Introduction: Colonoscopy is a method of endoscopy of lower gastrointestinal system which needs ‎proper colon preparation that allows proper assessment, diagnosis and treatment. There are different ‎methods of bowel preparation available. Therefore more research by critical nurses can result in ‎better care.‎

Objective: The aim of present study is to compare the routine method (Castor oil and Bisacodyl ‎tablet) and oral sodium phosphate on the level of patient’s acceptance in patient undergoing ‎colonoscopy.‎

 Methods: This is a Quasi-experimental study, which was done on ‎‏90‏‎ out patient candidates for ‎colonoscopy referring to Razi-educational center. Samples were randomly chosen on the visit day ‎and divided to ‎‏2‏‎ groups of experiment and control. Data collection instrument included a ‎demographic questionnaire and a checklist to assess the level of patient’s acceptance and bowel ‎preparation. Primarily demographic data form was filled at that time, and then intervention was ‎done for two groups with ‎‏45‏‎ samples. The patient acceptance checklist was filled by interview ‎method on the day of performing colonoscopy procedure.‎ Results: Finding indicated that patient’s acceptance was better with oral sodium phosphate and chi-‎square and Fisher’s exact tests showed a significant difference on the level of patient’s acceptance ‎‎(p< ‎‏0.000‏‎). ‎

Conclusion: According to this result oral liquid sodium phosphate has caused better acceptance ‎compared with routine regimes (Castor oil and Bisacodyl tablet) in patients under colonoscopy.‎

Full-Text [PDF 300 kb]   (6313 Downloads) |   |   Full-Text (HTML)  (1126 Views)  
Article Type : Research | Subject: Special
Received: 2014/08/23 | Accepted: 2014/08/23 | Published: 2014/08/23

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.